StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Tonight and tomorrow

<< Previous

Bullboard Posts

Next >>

Comment by brad129on May 15, 2023 12:36pm

82 Views

Post# 35448506

RE:Tonight and tomorrow

should be call after close, this allows him to give 45min talking and take 1-2 select questions then conclude prior to market opening.

Nailbiter2 wrote: StageZero's Chairman and CEO, James Howard-Tripp, will host an investor webcast and conference call at 8:30am ET on Tuesday May 16, 2023, reviewing the operational results and discussing business developments.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market